Analysis of the efficacy and safety of camrelizumab combined with chemotherapy for cervical cancer treatment

IntroductionIn this study, we explored the effectiveness and safety of the immune checkpoint inhibitor camrelizumab in combination with chemotherapy for the treatment of cervical cancer by investigating adverse effects and changes in tumor volume, tumor activity, and biochemical indices.MethodsIn th...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Song-Tian Yang, Shuang Yang, Ji Wang, Xiao-Ling Mu, Bo Yan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Subjects:	cervical cancer immunotherapy camrelizumab PD-1 combined therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1502701/full